WhiteGlove Health, a chronic care and population health management provider has acquired Glenridge HealthCare Solutions, a provider of technology-enabled network development and consulting services. WhiteGlove is a portfolio company of Enhanced Equity Funds and Biomark Capital.
WhiteGlove Health, Inc., a leading chronic care and population health management provider, announced the acquisition of Glenridge HealthCare Solutions, a premier provider of technology-enabled network development and consulting services. WhiteGlove is a portfolio company of Enhanced Equity Funds and Biomark Capital.
Founded in 1997 by the company’s President Terry Spoleti and headquartered in Columbia, MD, Glenridge offers a full suite of differentiated services utilizing proprietary tools and software that enable customers to outsource their mission-critical managed care network development and provider engagement needs. Glenridge is focused on creating reform-driven payor strategies and provider alliances and serves national and regional health plans and health systems in all fifty states.
“The acquisition of Glenridge strengthens WhiteGlove’s position as a key partner for payors as they continue to adapt to the new healthcare environment,” said Nicholas A. Balog, CEO of WhiteGlove. “WhiteGlove’s care management tools and value-based care product are highly synergistic with Glenridge’s service offering. The combination of these two leading and innovative businesses will help payors and providers improve patient care while containing costs. We are thrilled that Terry will continue to serve as Chief Innovation Officer to help us continue to grow the combined company.”
Ms. Spoleti, said, “We are proud of the company we have built and are excited by the vision of the combined business. By combining our two companies we are better situated to help our clients improve patient access to care, improve the quality of existing networks, and manage costs.”
About WhiteGlove Health
WhiteGlove Health is a leading mobile healthcare provider that is focused on both treating the individual and achieving improved overall health and well-being of populations. Our comprehensive healthcare strategy is to provide the highest quality care at the lowest cost through board-certified nurse practitioners. The WhiteGlove Health care model includes primary and acute care services; supporting individuals with chronic conditions and focusing on preventable and avoidable care by ensuring patients receive appropriate care after discharge from acute-care hospital facilities.
About Enhanced Equity Funds
Enhanced Equity Funds (“EEF”) is a private equity firm focused exclusively on investing in the healthcare industry. The firm’s collective industry expertise, relationships and investment strategy have facilitated the development of industry leading healthcare companies. EEF currently manages approximately $600 million of committed capital across two funds.
About Biomark Capital
Biomark Capital provides venture funding and assistance to mid to late-stage life science and healthcare companies focused on novel approaches to diagnostics, therapeutics, medical devices, and the use of digital health technologies. We share the drive and vision of our portfolio companies to collaborate with them in accelerating growth and building successful business ventures. Biomark Capital has over 50 years of combined venture capital management experience and $200M under management.